Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

PCI Biotech begins treatment in Amphinex study

Feb. 22, 2012

Full BOLERO-2 study results published

Feb. 22, 2012

FDA places clinical hold on Capesaris

Feb. 21, 2012

Novel inhibitor of V600-mutant B-raf shows antitumor activity in animal models

Feb. 21, 2012

Threshold Pharmaceuticals' phase IIb study in pancreatic cancer meets primary endpoint

Feb. 21, 2012

Fuso Pharmaceutical synthesizes new agents to treat cancer

Feb. 21, 2012

China Medical University presents new sodium/iodide cotransporter proteins

Feb. 21, 2012

Exelixis synthesizes lysophospholipid S1P1 receptor antagonists with antitumor potential

Feb. 21, 2012

EMA committee recommends conditional approval of Pixuvri

Feb. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...